These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1438107)

  • 21. Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test.
    van Rijn AF; van Rossum LG; Deutekom M; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
    J Public Health (Oxf); 2008 Dec; 30(4):461-5. PubMed ID: 18716047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Additional mailing phase for FIT after a medical offer phase: The best way to improve compliance with colorectal cancer screening in France.
    Piette C; Durand G; Bretagne JF; Faivre J
    Dig Liver Dis; 2017 Mar; 49(3):308-311. PubMed ID: 27810401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mass screening for colorectal cancer in France. Experience in 165,000 people in the department of Calvados].
    Launoy G; Herbert C; Vallée JP; Desoubeaux N; Réaud JM; Ollivier V; Bouvier V; Flachs A; Arsène D; Valla A; Gignoux M
    Gastroenterol Clin Biol; 1996; 20(3):228-36. PubMed ID: 8763059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Women's social conditions and their participation in Cervical Cancer Population Screening Program in Poland].
    Spaczyński M; Nowak-Markwitz E; Januszek-Michalecka L; Karowicz-Bilińska A
    Ginekol Pol; 2009 Nov; 80(11):833-8. PubMed ID: 20088397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
    Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P
    Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mass population screening for colorectal cancer: factors influencing subjects' choice of screening test.
    Frew E; Wolstenholme J; Whynes D
    J Health Serv Res Policy; 2001 Apr; 6(2):85-91. PubMed ID: 11357249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Worry associated with screening for colorectal carcinomas.
    Lindholm E; Berglund B; Kewenter J; Haglind E
    Scand J Gastroenterol; 1997 Mar; 32(3):238-45. PubMed ID: 9085461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds.
    Jørgensen OD; Kronborg O; Fenger C
    Gut; 2002 Jan; 50(1):29-32. PubMed ID: 11772963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect on compliance of a health education leaflet in colorectal cancer screening in general practice in central England.
    Hart AR; Barone TL; Gay SP; Inglis A; Griffin L; Tallon CA; Mayberry JF
    J Epidemiol Community Health; 1997 Apr; 51(2):187-91. PubMed ID: 9196650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Colorectal cancer screening: facts and questions].
    Faivre J; Dancourt V
    Gastroenterol Clin Biol; 2002 May; 26(5 Suppl):B86-93. PubMed ID: 12068275
    [No Abstract]   [Full Text] [Related]  

  • 31. Involvement of general practitioners in mass screening. Experience of a colorectal cancer mass screening programme in the Calvados region (France).
    Launoy G; Veret JL; Richir B; Reaud JM; Ollivier V; Valla A; Gignoux M
    Eur J Cancer Prev; 1993 May; 2(3):229-32. PubMed ID: 8490541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Participants' characteristics in a French colorectal cancer mass screening campaign.
    Herbert C; Launoy G; Thezee Y; Maurel J; Richir B; Reaud JM; Ollivier V; Pegulu L; Valla A; Gignoux M
    Prev Med; 1995 Sep; 24(5):498-502. PubMed ID: 8524725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interval cancers in screening with fecal occult blood test for colorectal cancer.
    Jensen BM; Kronborg O; Fenger C
    Scand J Gastroenterol; 1992 Sep; 27(9):779-82. PubMed ID: 1411286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The view from two sides: a qualitative study of community and medical perspectives on screening for colorectal cancer using FOBT.
    Clavarino AM; Janda M; Hughes KL; Del Mar C; Tong S; Stanton WR; Aitken JF; Leggett BA; Newman B
    Prev Med; 2004 Sep; 39(3):482-90. PubMed ID: 15313087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for colorectal cancer: current status in Japan.
    Saito H
    Dis Colon Rectum; 2000 Oct; 43(10 Suppl):S78-84. PubMed ID: 11052482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [General practitioners' experience in a mass screening campaign of colorectal cancers].
    Durand G; Arveux P; Milan C; Quelier C; Bedenne L; Faivre J
    Cah Sociol Demogr Med; 1992; 32(2-3):191-205. PubMed ID: 1297544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Performance of the Hemoccult test in the screening of colorectal cancer and adenoma. Results of 5 screening campaigns in Saône-et-Loire].
    Tazi MA; Faivre J; Lejeune C; Benhamiche AM; Dassonville F
    Gastroenterol Clin Biol; 1999 May; 23(5):475-80. PubMed ID: 10429850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case-control study to evaluate efficacy of screening for faecal occult blood.
    Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
    J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorectal cancer screening in LHU4 Chiavarese, Italy: ethical, methodological and outcome evaluations at the end of the first round.
    Ferrari Bravo M; De Conca V; Devoto GL; Sironi M; Mele R; Fumagalli A; Rimassa P; Rossi G; Zampogna A; Sticchi C; Gabutti G;
    J Prev Med Hyg; 2012 Mar; 53(1):37-43. PubMed ID: 22803318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer).
    Loss J; Eichhorn C; Nagel E
    Z Gastroenterol; 2006 Nov; 44(11):1127-34. PubMed ID: 17115353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.